Improvement in Renal Function in High Immunologic Risk Kidney Transplant Recipients Switched From Tacrolimus to Belatacept

被引：1
|
作者：
Gupta, G. [1 ]
Kumar, D. [1 ]
Cotterell, A. [1 ]
Sharma, A. [1 ]
Posner, M. [1 ]
Ren, Q. [1 ]
Posner, S. [1 ]
King, A. [1 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA 23284 USA
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
10.1097/00007890-201407151-01520
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
A203
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [21] Belatacept Immunosuppression in High Risk Liver Transplant Recipients
    Masters, Brian M.
    Sparkes, Tracy M.
    Hanish, Steven I.
    Potosky, Darryn R.
    Hutson, William R.
    Barth, Rolf N.
    LaMattina, John C.
    TRANSPLANTATION, 2015, 99 : 275 - 276
  • [22] Overall Infectious Complications Related to Belatacept Conversion in Comparison to Tacrolimus in Kidney Transplant Recipients
    Marvin, Jennifer E.
    Azar, Marwan M.
    Belfield, Kristen D.
    Do, Vincent
    Formica, Richard
    Cohen, Elizabeth A.
    PROGRESS IN TRANSPLANTATION, 2022, 32 (04) : 351 - 356
  • [23] Belatacept Vs. Tacrolimus: Clinical Outcomes in De Novo Kidney Transplant Recipients
    Wongsaroj, P.
    Kahwaji, J.
    Vo, A.
    Choi, J.
    Villicana, R.
    Peng, A.
    Jordan, S.
    TRANSPLANTATION, 2014, 98 : 457 - 457
  • [24] Cardiovascular Outcomes of Kidney Transplant Recipients Receiving Belatacept Compared to a Matched Tacrolimus.
    Kim, Y.
    Marvin, J.
    Belfield, K.
    Girone, G.
    Formica, R.
    Cohen, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 684 - 684
  • [25] Infections in Kidney Transplant Recipients on Belatacept versus Tacrolimus-Based Immunosuppression.
    Gattis, S.
    Basu, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 933 - 934
  • [26] Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high-risk cytomegalovirus serostatus kidney transplant recipients
    Magua, Wairimu
    Johnson, Aileen C.
    Karadkhele, Geeta M.
    Badell, Idelberto R.
    Vasanth, Payaswini
    Mehta, Aneesh K.
    Easley, Kirk A.
    Newell, Kenneth A.
    Rickert, Joseph B.
    Larsen, Christian P.
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (06)
  • [27] Impact of Belatacept and Tacrolimus on Cmv Viral Load Control and Relapse in Moderate and High-risk Cmv Serostatus Kidney Transplant Recipients
    Magua, W.
    Johnson, A. C.
    Karadkhele, G. M.
    Badell, I. R.
    Vasanth, P.
    Lyon, G., III
    Mehta, A. K.
    Easley, K. A.
    Rickert, J.
    Larsen, C. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 632 - 632
  • [28] Incidence of Opportunistic Infection in Kidney Transplant Recipients Receiving Belatacept versus Tacrolimus Early Post Transplant
    Wong, A.
    Jonchhe, S.
    Lewis, T.
    Stern, J.
    Robalino, R.
    Dubrovskaya, Y.
    Papadopoulos, J.
    Lewis, Z. Stewart
    Mehta, S.
    Ali, N.
    Neumann, H.
    Khalil, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S849 - S849
  • [29] Effect of Tacrolimus Metabolism Rate on Renal Function Among Hispanic Kidney Transplant Recipients
    Min, D. I.
    Shah, T.
    Qazi, Y. A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1123 - S1124
  • [30] Patient and Graft Outcome among High Immunologic Risk Renal Transplant Recipients
    Mora, Jeffrey
    Cabanayan-Casasola, Concesa B.
    Padua, Florecita R.
    Mendoza, Myrna T.
    TRANSPLANTATION, 2018, 102 : S485 - S486
12345